Neurodiagnostics Market accounted for US$ 7.22 billion in 2022 and is estimated to be US$ 17.8 billion by 2032 and is anticipated to register a CAGR of 11.8% – By PMI
Neurodiagnostics Market, By Type (In-vitro Diagnostics, Imaging Systems, Molecular Diagnostics, Computed Tomography (CT), Electroencephalogram Systems, and Others), By End-Users (Hospitals,…